The terms are used inconsistently across markets, which is why two quotations described in the same words can commit a brand to very different arrangements. The labels matter less than the three questions hiding behind them: who developed the product, who owns it, and who else can buy it.
| Term | Common meaning | The question it leaves open |
|---|---|---|
| Private label | The manufacturer's existing formula, sold under the brand's own name | Whether the same formula is offered to competitors, and on what basis |
| Contract manufacturing | The brand specifies the product and the manufacturer produces it | Who owns the specification, and what happens if the brand wants to move |
| OEM | Used in some markets for contract manufacturing; in others for a manufacturer's own brand being produced for another party | Which of the two the supplier means by it |
| ODM | Usually describes a manufacturer that develops the product as well as producing it | Whether the formula transfers to the brand or remains the manufacturer's |
Because usage varies, the practical discipline is to describe your arrangement in plain language in the agreement rather than to rely on a term. "You will produce our specification, we own it, and you will not supply it to anyone else in our market" is unambiguous. "OEM" is not.
Speed and cost of reaching market. An existing private-label formula can usually reach packaging faster than a developed one, because formulation and stability work has already been done. A contract-manufactured product requires development, iteration and its own stability programme, which takes time and money — and may be worth it where the positioning depends on a specific composition.
Differentiation. A private-label formula is by definition available to others. Where several brands in the same market buy the same base, the product competes on packaging, price and marketing rather than on formulation. A contract-manufactured or developed formula can be exclusive, which is often the reason a brand chooses that route.
Ownership and mobility. This is where the choice has the longest consequences. Where the manufacturer owns the formula, moving production later may not be possible at all. Where the brand owns it, the handover documentation determines whether that ownership is practical — a formula name is not a transfer. We cover the arrangements in who owns the formula.
Exclusivity. A brand buying an existing formula can still ask for exclusive use in a market, a channel or a period. That is a commercial commitment for the manufacturer and is normally priced — sometimes into the unit cost, sometimes as a volume commitment. It is worth deciding whether exclusivity is genuinely needed, or whether owning a developed formula achieves the same protection at a different cost.
Three questions in sequence usually resolve it. Does the product's positioning depend on a composition nobody else can sell? If yes, a developed or exclusive arrangement is required, and the extra cost and time belong in the plan. If no, a private-label base is faster and cheaper, and differentiation has to come from elsewhere.
Then: what does the brand intend to do in three years? A brand that expects to scale, or to change manufacturers, should own its formula from the outset if it can. And finally: which arrangement is actually being quoted? Asking a supplier to state in writing which of the four arrangements applies to your product is a short conversation that prevents a long misunderstanding.
Usually, because the formulation work already exists and development is not charged. The trade-off is that the same base is available to other brands.
It can be granted, and it is a commercial negotiation with boundaries — territory, channel, duration and scope. It is normally priced accordingly.
Which arrangement applies, who developed and owns the formula, what exclusivity is granted and on what terms, and what documentation the brand receives.
More guides in this group:
Browse all guides and products
Deciding which arrangement suits your product? Shandong Guihe Pet Food Co., Ltd. manufactures pet supplements and pet food in Yishui County, Linyi, Shandong, with a 12,000 m² plant and 30,000 tons of annual capacity. See our OEM & ODM services, read who owns the formula, or see how formulation development works.